Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

526 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reply to Ambrosioni et al.
Günthard HF, Calvez V, Paredes R, Pillay D, Shafer RW, Wensing AM, Jacobsen DM, Richman DD. Günthard HF, et al. Among authors: calvez v. Clin Infect Dis. 2019 May 17;68(11):1977-1978. doi: 10.1093/cid/ciy1022. Clin Infect Dis. 2019. PMID: 30520997 No abstract available.
Clinically validated genotype analysis: guiding principles and statistical concerns.
Brun-Vézinet F, Costagliola D, Khaled MA, Calvez V, Clavel F, Clotet B, Haubrich R, Kempf D, King M, Kuritzkes D, Lanier R, Miller M, Miller V, Phillips A, Pillay D, Schapiro J, Scott J, Shafer R, Zazzi M, Zolopa A, DeGruttola V. Brun-Vézinet F, et al. Among authors: calvez v. Antivir Ther. 2004 Aug;9(4):465-78. Antivir Ther. 2004. PMID: 15456077 Review.
Optimal use of maraviroc in clinical practice.
Soriano V, Geretti AM, Perno CF, Fätkenheuer G, Pillay D, Reynes J, Tambussi G, Calvez V, Alcamí J, Rockstroh J. Soriano V, et al. Among authors: calvez v. AIDS. 2008 Nov 12;22(17):2231-40. doi: 10.1097/QAD.0b013e3283136d95. AIDS. 2008. PMID: 18981762 Review. No abstract available.
Predictive value of HIV-1 genotypic resistance test interpretation algorithms.
Rhee SY, Fessel WJ, Liu TF, Marlowe NM, Rowland CM, Rode RA, Vandamme AM, Van Laethem K, Brun-Vezinet F, Calvez V, Taylor J, Hurley L, Horberg M, Shafer RW. Rhee SY, et al. Among authors: calvez v. J Infect Dis. 2009 Aug 1;200(3):453-63. doi: 10.1086/600073. J Infect Dis. 2009. PMID: 19552527 Free PMC article.
When and how to use maraviroc in HIV-infected patients.
Soriano V, Perno CF, Kaiser R, Calvez V, Gatell JM, di Perri G, Pillay D, Rockstroh J, Geretti AM. Soriano V, et al. Among authors: calvez v. AIDS. 2009 Nov 27;23(18):2377-85. doi: 10.1097/QAD.0b013e328332d32d. AIDS. 2009. PMID: 19834318 Review. No abstract available.
2011 update of the drug resistance mutations in HIV-1.
Johnson VA, Calvez V, Günthard HF, Paredes R, Pillay D, Shafer R, Wensing AM, Richman DD. Johnson VA, et al. Among authors: calvez v. Top Antivir Med. 2011 Nov;19(4):156-64. Top Antivir Med. 2011. PMID: 22156218 Free PMC article. Review.
Update of the drug resistance mutations in HIV-1: March 2013.
Johnson VA, Calvez V, Gunthard HF, Paredes R, Pillay D, Shafer RW, Wensing AM, Richman DD. Johnson VA, et al. Among authors: calvez v. Top Antivir Med. 2013 Feb-Mar;21(1):6-14. Top Antivir Med. 2013. PMID: 23596273 Free PMC article. No abstract available.
526 results